Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
A common reason why patients want to switch weight-loss medications is due to side effects
Current FDA-approved GLP-1 drugs available on the market include: Byetta (exenatide) Foundayo (orforglipron) Trulicity (dulaglutide), Victoza, Saxenda, Xultophy (liraglutide) Ozempic, Rybelsus, Wegovy (semaglutide) Mounjaro, Zepbound (tirzepatide) While all GLP-1 drugs can cause weight loss as a side effect, only Wegovy, Saxenda, Foundayo, and Zepbound are FDA approved for weight loss
Protocols that already use Wolverine (BPC-157 + TB-500) and want to add a tissue-quality layer
We also monitor ongoing research into the potential benefits of these injections for treating other conditions such as obesity without diabetes and cardiovascular diseases
US$ 29.61
US$ 29.37
US$ 27.14
US$ 24.75
